Our partner Alzheimer Hellas had the opportunity to present 2D-BioPAD at the hybrid scientific workshop “Controversies in Neuropsychological Assessment” in Thessaloniki, Greece.
In the opening session, focused on whether neuropsychological assessment can (or should) be replaced by biomarkers, we shared our work with 150 doctors and psychologists, joining both on-site and online.
A lively discussion, critical questions, and a forward-looking audience made this the perfect setting to highlight how 2D-BioPAD fits into the future of cognitive assessment.
